Does Semaglutide Stop Periods or Change Your Cycle?

What the STEP trials and regulatory data recorded, and what they didn't

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults with obesity over 68 weeks on 2.4 mg semaglutide. Menstrual disturbance did not appear among the adverse events that reached the reporting threshold. That is a factual statement about statistical frequency, not a reassurance that cycles are unaffected. Clinical trials are powered to detect outcomes at population scale; individual hormonal variation, which is substantial, sits beneath that level of detection.

The NHS medicines page for semaglutide lists the common and uncommon side effects as primarily gastrointestinal, nausea, vomiting, constipation, diarrhoea, and reflux. Menstrual changes are not among them. What the NHS does flag clearly is the need for effective contraception throughout treatment, precisely because fertility can recover as body weight decreases. Those two things coexist: the medicine itself may not directly halt periods, but the weight-loss process it drives can shift the hormonal balance enough to change your cycle.

Worth knowing: if your periods have been absent or infrequent for years due to excess weight, some women report cycles returning during GLP-1 treatment. That is not a side effect of the medicine in the conventional sense, it is a consequence of improved ovulatory function as metabolic health improves.

How rapid weight loss influences cycle length and regularity

Body fat is metabolically active. Adipose tissue produces oestrogen, and the ratio between fat mass, lean mass, and central adiposity influences the hormonal signalling that governs the menstrual cycle. When weight falls quickly (as it can with semaglutide, particularly in the first few months of treatment) that hormonal environment shifts. The hypothalamic-pituitary-ovarian axis, which coordinates ovulation, is sensitive to energy availability and leptin signalling, both of which change during caloric restriction and weight loss.

The practical result for some women is a temporary disruption to cycle timing: a period arriving earlier or later than expected, a cycle that lengthens from 28 to 35 days, or one that shortens. Heavier or lighter bleeds during the transition phase are also reported anecdotally, though the evidence base here is observational rather than from controlled trials. Most of these changes settle once weight stabilises, though there is no precise timeline the evidence supports.

A simple checking habit: keep a basic note on your phone of when each period starts. One line, one date. Over three months, a pattern either emerges or it doesn't, and if you're heading into a prescriber review, that log is immediately useful. Our page on semaglutide absorption explains the broader pharmacokinetic picture for anyone curious about how the medicine behaves week to week.

Periods stopping entirely, when to take it seriously

Amenorrhoea (the absence of periods for three or more months) during semaglutide treatment warrants a conversation with a clinician, not because the medicine is the assumed cause, but because the differential is wide. Weight-related hormonal recovery, pregnancy (see below), thyroid changes, hyperprolactinaemia, polycystic ovary syndrome flaring or settling, all can present as missed periods in a woman whose weight and metabolic profile are in flux.

Pregnancy is a particular consideration. As body weight falls and insulin sensitivity improves, ovulation can resume in women who previously had irregular or absent cycles. Semaglutide is not recommended during pregnancy, and the current guidance is to use effective contraception throughout treatment. If you are specifically wondering whether Wegovy can stop your periods, that question involves several overlapping factors that are worth understanding before drawing any conclusions. Our page covering how Wegovy affects periods goes into the contraception picture in more detail.

The NHS England guidance on weight management injections is explicit that women of childbearing age should discuss contraception with their prescriber before starting treatment. That conversation is part of the clinical assessment, not an afterthought.

Getting clinical support if your cycle has changed

If you started semaglutide and your periods became irregular, lighter, heavier, or have paused, the right route is to raise it with a prescriber, either the one managing your treatment or your GP. There is no single expected outcome: some women's cycles normalise, some become more regular, and some experience disruption during the active weight-loss phase. None of that means treatment needs to stop, but it does mean a clinician should be in the loop.

At nume (at a GPhC-registered online pharmacy like ours) every repeat order is reviewed by a named prescriber, not processed automatically. Questions about cycle changes, contraception, or anything else that has shifted since the last dose can be raised through aftercare, seven days a week. If you are at an earlier stage and wondering whether semaglutide treatment is appropriate for your situation, the sensible starting point is a free consultation where the full clinical picture is considered. You can read more about Wegovy as a licensed weight-loss treatment or explore all of nume's treatment options and check your eligibility with our prescribers. A broader look at whether semaglutide stops your period entirely may also answer questions specific to that scenario.